Related Articles
Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors
Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressaâ„¢)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)
Genetic alterations of HER genes in chromophobe renal cell carcinoma
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands